An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia



Status:Approved for marketing
Conditions:Blood Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:August 2013
End Date:January 2014

Use our guide to learn which trials are right for you!

This is a multicenter, open-label, single-arm, expanded access treatment study designed to
provide obinutuzumab to patients with previously untreated CLL in combination with
chlorambucil and to evaluate the safety and efficacy of obinutuzumab administered in
combination with chlorambucil. This study will enroll patients with previously untreated
CD20-positive CLL requiring treatment according to the IWCLL guidelines (Hallek et al 2008),
as assessed by the investigator.


Inclusion Criteria:

- Confirmed diagnosis of CD20-positive CLL (per IWCLL guidelines, Hallek et al 2008)

- Previously untreated CLL requiring treatment according to the IWCLL guidelines
(Hallek et al 2008), as assessed by the investigator

- Adequate baseline bone marrow function unless it due to underlying CLL disease No
previous treatment for CLL by chemotherapy, radiotherapy, or immunotherapy

- Patients who are not appropriate to receive more intensive chemotherapy in the
judgment of the investigator

- Life expectancy of > 6 months

Exclusion Criteria:

- Treatment with any other investigational agent or participation in another clinical
trial within 28 days prior to the start of Cycle 1

- Transformation of CLL to aggressive B-cell malignancy History of severe allergic or
anaphylactic reactions to monoclonal antibody therapy

- Known hypersensitivity to chlorambucil or any of its excipients

- History of other malignancy that could affect compliance with the protocol or
interpretation of results Known active bacterial, viral, fungal, mycobacterial, or
other infection (excluding fungal infections of nail beds) or any major episode of
infection requiring treatment with IV antibiotics or hospitalization (related to the
completion of the course of antibiotics) within 4 weeks before the start of Cycle 1

- Major surgery (within 4 weeks prior to the start of Cycle 1), other than for
diagnosis

- Known infection with human immunodeficiency virus (HIV) or Human T-Cell Leukemia
Virus 1 (HTLV-1) seropositive status

- Positive hepatitis serology

- Women who are pregnant or lactating

- Fertile men or women of childbearing potential unless 1) surgically sterile or 2)
using an adequate measure of contraception such as oral contraceptives, intrauterine
device, or barrier method of contraception in conjunction with spermicidal jelly

- Effective contraception is required while receiving obinutuzumab. For women,
effective contraception is required to continue for >= 12 months after the last dose
of obinutuzumab. For men, effective contraception is required to continue for 6
months after the last dose of chlorambucil treatment.

- Vaccination with a live vaccine a minimum of 28 days prior to the start of Cycle 1
We found this trial at
20
sites
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Charleston, South Carolina 29412
?
mi
from
Charleston, SC
Click here to add this to my saved trials
?
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Farmington, NM
Click here to add this to my saved trials
?
mi
from
Galesburg, IL
Click here to add this to my saved trials
?
mi
from
Goshen, IN
Click here to add this to my saved trials
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
?
mi
from
Huntsville, AL
Click here to add this to my saved trials
?
mi
from
Joliet, IL
Click here to add this to my saved trials
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
?
mi
from
Lafayette, IN
Click here to add this to my saved trials
?
mi
from
Marietta, GA
Click here to add this to my saved trials
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
?
mi
from
Peoria, IL
Click here to add this to my saved trials
Pleasant Hill, California 94522
?
mi
from
Pleasant Hill, CA
Click here to add this to my saved trials
?
mi
from
Rogers, AR
Click here to add this to my saved trials
?
mi
from
Southington, CT
Click here to add this to my saved trials
?
mi
from
Tacoma, WA
Click here to add this to my saved trials